Endoproteolysis of Glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells

Peptides

Volumn 18, Issue 5, 1997, Pages 625-632

  Hupe Sodmann, Karin ^a   Göke, Rüdiger ^a   Göke, Burkhard ^a   Thole, Hubert H ^b,d   Zimmermann, Bodo ^c   Voigt, Karlheinz ^a   McGregor, Gerard P ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Ectopeptidases; GLP 1; Insulinotropic peptides; Peptidase assays; Peptide metabolism; RINm5F Cells

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; PEPTIDASE;

ARTICLE; HUMAN; HUMAN CELL; INSULIN METABOLISM; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; GASTROINTESTINAL HORMONES; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; HYDROLYSIS; INSULINOMA; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; RATS; TUMOR CELLS, CULTURED;

EID: 0030758090     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00123-X     Document Type: Article

References (24)

1. Back S. A., Gorenstein C. Fluorescent histochemical localisation of neutral endopeptidase 24.11 (enkephalinase) in the rat spinal cord. J. Comp. Neurol. 280:1989;436-450.
2. Berggsen P. O., Rorsman P., Efendic S., Ostenson C. G., Flatt P. R., Nilsson T., Arkhammar P., Juntti-Berggsen L. Mechanisms of action of entero-insular hormones, islet peptides and neural input on the insulin secretory process. Flatt P. R. Nutrient regulation of insulin secretion. 318;289-318 Portland Press, London/Chapel Hill.
3. Bunnett N. W. Release and breakdown; postsecretory processing of peptides. Am. Rev. Respir. Dis. 136:1987;s27-s34.
4. Byrne M. M.Göke B. Human studies with glucagon-like peptide-1: Potential for clinical use. Diabetic Medicine, (in press).
5. 2-terminus in Type II diabetic patients and in healthy subjects. Diabetes. 44:1995;126-1131.
6. Gazdar A. F., Chick W. L., Oie H. K., Sims H. L., King D. L., Weir G. C., Lauris V. Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet tumor. Proc. Natl. Acad. Sci. USA. 77:1980;3519-3523.
7. Grandt D., Sieburg B., Siervert J., Schimiczek M., Becker U., Holtmann B., Layer P., Reeve J. R., Eysselein V. E., Goebell H., Müller M. Is GLP-1 (9-36) amide an endogenous antagonist at GLP-1 receptors? Digestion. 55:([Abstract]):1994;302A.
8. Fehmann H.-C., Göke R., Göke B. Cell and molecular biology of the incretin hormones, glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide. Endocr. Rev. 16:1995;390-410.
9. Fehmann H.-C., Habener J. F. Insulinotropic glucagon-like peptide-1 (7-37)(7-36) amide: A new incretin hormone. Trends Endocrinol. Metabol. 3:1992;158-163.
10. Gefel D., Hendrick J. K., Mojsov S., Habener J. F., Weier G. C. Glucagon-like peptide-1-analogues: Effect on insulin secretion and cAMP formation. Endocrinology. 126:1990;2164-2168.
11. Göke R., Oltmer B., Sheikh S. P., Göke B. Solubilisation of active GLP-1 (7-36) amide receptors from RINm5F membranes. FEBS Lett. 300:1992;232-236.
12. Hupe-Sodmann K., McGregor G. P., Bridenbaugh R., Göke R., Göke B., Thole H., Zimmermann B., Voigt K. Characterization of the processing by neutral endopeptidase 24.11 of GLP-1 (7-36) amide and comparison of the subtrate specificiy of the enzyme for other glucagon-like peptides. Reg. Pep. 58:1995;149-156.
13. Kenny A. J., Hooper N. M. Peptidases involed in the metabolism of bioactive peptides. Henrrickson J. Degradation of bioactive substances: Physiology and pathophysiology. 1991;47-79 CRL Press, Boca Raton.
14. Kreymann B., Ghatei M. A., Williams G., Bloom S. R. Glucagon-like peptide-1 (7-36) amide: A physiological incretin in man. Lancet. 2:1987;1300-1303.
15. Mentlein R., Gallwitz B., Schmidt W. E. Dipeptidyl-peptidase IV hydrtolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214:1993;829-835.
16. Mojsov S., Weir G. C., Habener J. F. Insulinotropin: Glucagon-like peptide-1 (7-37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79:1987;616-619.
17. Noggle J. H. Practical curve fitting and data analysis. Software and self instruction for scientist and engineers. Chichester, USA: Prentice Hall, Inc. 1993.
18. Orlowski M., Wilk S. Purification and specificity of a membrane-bound metallopeptidase from bovine pituitaries. Biochemistry. 20:1981;4942-4950.
19. Orskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:1992;701-711.
20. Orskov C., Wettergren A., Holst J. J. Biological effects and metabolic rates of glucagon-like peptide-1 (7-36) amide and glucagon-like peptide (7-37) in healthy subjects are indistinguishable. Diabetes. 43:1993;658-661.
21. Roques B. P., Noble F., Dauge V., Fournie-Zaluski M.-C., Beaumont A. Neutral endopeptidase 24.11: Structure, inhibition and experimental and clinical pharmacology. Pharmacol. Rev. 45:1993;87-146.
22. Schnabel R., Bernstein H. G., Luppa H., Lojda Z., Barth A. Aminopeptidases in the circumventricular organs of the mouse brain: A histochemical study. Neuroscience. 47:1992;431-438.
23. Suzuki S., Kawai K., Ohasi S., Mukai H., Yamashita K. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Endocrinology. 125:1989;3109-3114.
24. ++ and insulin release in an insulin-secreting cell line. J. Biol. Chem. 259:1984;2262-2267.